Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review

Neuronal pentraxin 2 (NP2) plays a significant role in synaptic plasticity, neuronal survival, and excitatory synapse regulation. Emerging research suggests that NP2 is implicated in the pathogenesis of various neurological disorders, including neurodegenerative diseases, neuropsychiatric disorders,...

Full description

Saved in:
Bibliographic Details
Main Authors: Ubaid Ansari, Jimmy Wen, Burhaan Syed, Dawnica Nadora, Romteen Sedighi, Denise Nadora, Vincent Chen, Forshing Lui
Format: Article
Language:English
Published: AIMS Press 2024-12-01
Series:AIMS Neuroscience
Subjects:
Online Access:https://www.aimspress.com/article/doi/10.3934/Neuroscience.2024031
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590280373567488
author Ubaid Ansari
Jimmy Wen
Burhaan Syed
Dawnica Nadora
Romteen Sedighi
Denise Nadora
Vincent Chen
Forshing Lui
author_facet Ubaid Ansari
Jimmy Wen
Burhaan Syed
Dawnica Nadora
Romteen Sedighi
Denise Nadora
Vincent Chen
Forshing Lui
author_sort Ubaid Ansari
collection DOAJ
description Neuronal pentraxin 2 (NP2) plays a significant role in synaptic plasticity, neuronal survival, and excitatory synapse regulation. Emerging research suggests that NP2 is implicated in the pathogenesis of various neurological disorders, including neurodegenerative diseases, neuropsychiatric disorders, and neuropathies. This literature review extensively analyzes NP2's role in these conditions, thereby highlighting its contributions to synaptic dysfunction, neuroinflammation, and neurotoxic protein aggregation. In Alzheimer's and Parkinson's diseases, NP2 is linked to amyloid-beta aggregation and dopaminergic neuron degeneration, respectively. Additionally, altered NP2 expression is observed in schizophrenia and bipolar disorder, thus suggesting its involvement in synaptic dysfunction and neurotransmitter imbalance. In neuropathic pain and epilepsy, NP2 modulates the synaptic plasticity and inflammatory responses, with altered levels correlating with disease severity. Furthermore, NP2's involvement in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) emphasizes its broad impact on neuronal health. Understanding NP2's multifaceted roles may reveal novel therapeutic targets and improve the clinical outcomes for these neurological disorders. Though the precise role of NP2 remains uncertain, its clinical potential and initial findings justify further investigations into neuronal pentraxins and other related neuroproteins.
format Article
id doaj-art-b71ef6fe675f43198712dbf7cf9ad95f
institution Kabale University
issn 2373-7972
language English
publishDate 2024-12-01
publisher AIMS Press
record_format Article
series AIMS Neuroscience
spelling doaj-art-b71ef6fe675f43198712dbf7cf9ad95f2025-01-24T01:29:33ZengAIMS PressAIMS Neuroscience2373-79722024-12-0111450551910.3934/Neuroscience.2024031Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature reviewUbaid Ansari0Jimmy Wen1Burhaan Syed2Dawnica Nadora3Romteen Sedighi4Denise Nadora5Vincent Chen6Forshing Lui7California Northstate University College of Medicine, USACalifornia Northstate University College of Medicine, USACalifornia Northstate University College of Medicine, USACalifornia Northstate University College of Medicine, USACalifornia Northstate University College of Medicine, USACalifornia Northstate University College of Medicine, USACalifornia Northstate University College of Medicine, USACalifornia Northstate University College of Medicine, USANeuronal pentraxin 2 (NP2) plays a significant role in synaptic plasticity, neuronal survival, and excitatory synapse regulation. Emerging research suggests that NP2 is implicated in the pathogenesis of various neurological disorders, including neurodegenerative diseases, neuropsychiatric disorders, and neuropathies. This literature review extensively analyzes NP2's role in these conditions, thereby highlighting its contributions to synaptic dysfunction, neuroinflammation, and neurotoxic protein aggregation. In Alzheimer's and Parkinson's diseases, NP2 is linked to amyloid-beta aggregation and dopaminergic neuron degeneration, respectively. Additionally, altered NP2 expression is observed in schizophrenia and bipolar disorder, thus suggesting its involvement in synaptic dysfunction and neurotransmitter imbalance. In neuropathic pain and epilepsy, NP2 modulates the synaptic plasticity and inflammatory responses, with altered levels correlating with disease severity. Furthermore, NP2's involvement in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) emphasizes its broad impact on neuronal health. Understanding NP2's multifaceted roles may reveal novel therapeutic targets and improve the clinical outcomes for these neurological disorders. Though the precise role of NP2 remains uncertain, its clinical potential and initial findings justify further investigations into neuronal pentraxins and other related neuroproteins.https://www.aimspress.com/article/doi/10.3934/Neuroscience.2024031neuronal pentraxin 2synaptic plasticityalzheimer's diseaseparkinson's diseaseschizophrenianeuropathic painepilepsyamyotrophic lateral sclerosis
spellingShingle Ubaid Ansari
Jimmy Wen
Burhaan Syed
Dawnica Nadora
Romteen Sedighi
Denise Nadora
Vincent Chen
Forshing Lui
Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review
AIMS Neuroscience
neuronal pentraxin 2
synaptic plasticity
alzheimer's disease
parkinson's disease
schizophrenia
neuropathic pain
epilepsy
amyotrophic lateral sclerosis
title Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review
title_full Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review
title_fullStr Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review
title_full_unstemmed Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review
title_short Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review
title_sort analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders a literature review
topic neuronal pentraxin 2
synaptic plasticity
alzheimer's disease
parkinson's disease
schizophrenia
neuropathic pain
epilepsy
amyotrophic lateral sclerosis
url https://www.aimspress.com/article/doi/10.3934/Neuroscience.2024031
work_keys_str_mv AT ubaidansari analyzingthepotentialofneuronalpentraxin2asabiomarkerinneurologicaldisordersaliteraturereview
AT jimmywen analyzingthepotentialofneuronalpentraxin2asabiomarkerinneurologicaldisordersaliteraturereview
AT burhaansyed analyzingthepotentialofneuronalpentraxin2asabiomarkerinneurologicaldisordersaliteraturereview
AT dawnicanadora analyzingthepotentialofneuronalpentraxin2asabiomarkerinneurologicaldisordersaliteraturereview
AT romteensedighi analyzingthepotentialofneuronalpentraxin2asabiomarkerinneurologicaldisordersaliteraturereview
AT denisenadora analyzingthepotentialofneuronalpentraxin2asabiomarkerinneurologicaldisordersaliteraturereview
AT vincentchen analyzingthepotentialofneuronalpentraxin2asabiomarkerinneurologicaldisordersaliteraturereview
AT forshinglui analyzingthepotentialofneuronalpentraxin2asabiomarkerinneurologicaldisordersaliteraturereview